From formulary access to patient support programs, we have your patients covered.
KEVZARA IS NOW PREFERRED WITH NO STEP EDIT AT CVS CAREMARK Rx FOR COMMERCIALLY INSURED PATIENTS
OF COMMERCIALLY INSURED PATIENTS HAVE ACCESS TO KEVZARA
PLAN NAME | KEVZARA COVERAGE STATUS |
LIVES IMPACTED |
---|---|---|
Commercial* | ||
Aetna | Preferred access: covered for first-line use following cDMARD | 2 million |
Anthem | Covered for use after failure on TWO of the following– Enbrel®, Humira®, Rinvoq™, Simponl® |
13 million |
BCBS FEP | Covered for use after failure on ONE of the following– Humira® or Enbrel® |
6 million |
CIGNA | Covered for use after failure on any TWO of the following– Humira®, Enbrel®, Rinvoq™, Xeljanz®, Actemra® |
6 million |
CVS (Advanced Control Specialty Formulary) |
Preferred access: covered for first-line use following cDMARD | 16 million |
ESI | Covered for use after failure on any TWO of the following– Humira®, Enbrel®, Rinvoq™, Xeljanz®, Actemra® |
40 million |
Humana | Preferred access: covered for first-line use following cDMARD | 1 million |
Prime Clients | Covered for use after failure on any TWO of the following–
Humira®, Enbrel®, Rinvoq™, Xeljanz®, Actemra® |
10 million |
Tricare | Covered for use after failure on Humira® | 7 million |
VA | Covered for use after failure on Enbrel® | 9 million |
Medicare* | ||
ESI | Covered for use after failure on any TWO of the following– Humira®, Enbrel®, Rinvoq™, Xeljanz®, Actemra® |
1 million |
Humana | Preferred access: covered for first-line use following cDMARD | 8 million |
Managed Medicaid* | ||
Anthem | Covered for use after failure on: Humira® and Enbrel® |
3 million |
CVS | Preferred access: covered for first-line use following cDMARD | 15 million |
Formulary data are provided by Managed Markets Insight Technology, LLC, and are current as of 01/2021. Utilization management criteria shown represent CVS Caremark Rx's Advanced Control Specialty Formulary (ACSF). According to these data, the ACSF makes up ~55% of CVS Caremark Rx's commercially insured lives.
A majority of commercially insured patients, 82%, have access to KEVZARA after trying
and failing with up to 2 products (double-step edit).
KevzaraConnect® is designed to support and simplify the KEVZARA journey
for your patients by providing coverage support, including assistance
with navigating the complex insurance process.